Stay updated on Romiplostim & Danazol in ITP Clinical Trial
Sign up to get notified when there's something new on the Romiplostim & Danazol in ITP Clinical Trial page.

Latest updates to the Romiplostim & Danazol in ITP Clinical Trial page
- CheckyesterdayChange DetectedA new Revision: v3.3.4 was added and Revision: v3.3.3 was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a new record history entry Revision: v3.3.3. Removed the HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry from the footer/history.SummaryDifference0.2%

- Check51 days agoChange DetectedThe record history shows a new site revision v3.3.2 replacing v3.2.0. The change is a backend/UI update with no impact on trial data or study details.SummaryDifference0.1%

- Check58 days agoChange DetectedNotice about government funding lapse and operating status was removed from the page.SummaryDifference0.8%

- Check73 days agoChange DetectedThe latest history entry shows no changes to the study record. This does not affect study details or other information on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.SummaryDifference13%

Stay in the know with updates to Romiplostim & Danazol in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Romiplostim & Danazol in ITP Clinical Trial page.